Literature DB >> 6794013

In vitro LHRH release: correlation with the LH surge and alteration by a mammary carcinogen.

B Kerdelhue, E J Peck.   

Abstract

The releasability of LHRH from neurosecretory terminals, as assessed in vitro by depolarization of hypothalamic synaptosomes with elevated K+, varies as a function of the time of day in parallel with the LH surge. Pretreatment of ovariectomized female rats with dimethylbenz(a)anthracene (DMBA) results in a blockade of the estrogen-induced LH surge and a blunting of LHRH release as measured in vitro. An examination of the LHRH release process revealed that K+-stimulated release of particulate LHRH was inhibited by DMBA pretreatment while basal release of particulate LHRH and both basal and K+-stimulated release of soluble LHRH were not altered. These results suggest that release of particulate LHRH is closely coupled with the estrogen-induced LH surge.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794013     DOI: 10.1016/s0196-9781(81)80037-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  2 in total

1.  Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague-Dawley rat.

Authors:  Véronique Lenoir; Marianne Beau Yon de Jonage-Canonico; Marie-Hélène Perrin; Antoine Martin; Robert Scholler; Bernard Kerdelhué
Journal:  Breast Cancer Res       Date:  2005-04-29       Impact factor: 6.466

Review 2.  Dimethyl-Benz(a)anthracene: A mammary carcinogen and a neuroendocrine disruptor.

Authors:  Bernard Kerdelhué; Claude Forest; Xavier Coumoul
Journal:  Biochim Open       Date:  2016-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.